Quantcast
Home > Quotes > NOVN

Novan, Inc. Common Stock (NOVN) Quote & Summary Data

NOVN 
$2.42
*  
0.04
1.63%
Get NOVN Alerts
*Delayed - data as of Aug. 23, 2019  -  Find a broker to begin trading NOVN now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 2.47 / $ 2.37
Share Volume
9,329
50 Day Avg. Daily Volume
57,977
Previous Close
$ 2.46
52 Week High / Low
$ 3.2399 / $ 0.65
Market Cap
63,088,756
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
9,329
50 Day Avg. Daily Volume:
57,977

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.55

Trading Range

The current last sale of $2.42 is 272.31% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.47 $ 3.2399
 Low: $ 2.37 $ 0.65

ETFs with NOVN as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
11.72% iShares Inc iShares MSCI Switzerland ETF (EWL) +1.55 (4.35%)
5.11% Invesco S&P International Developed Quality ETF (IDHQ) +0.43 (1.86%)
4.61% iShares Global Healthcare ETF (IXJ) -0.26 (-0.42%)
3.59% Vanguard International Dividend Appreciation ETF (VIGI) -0.23 (-0.35%)
3.04% iShares Trust (IGRO) -1.72 (-3.13%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a clinical development-stage biotechnology company focused on leveraging nitric oxide's naturally occurring anti-microbial and immunomodulatory mechanisms of action to treat a range of diseases with significant unmet needs. Nitric oxide plays a vital role in the natural immune system response against microbial pathogens and is a critical regulator of inflammation. Our ability to harness nitric oxide and its multiple mechanisms of action has enabled us to create a platform with the potential to generate differentiated product candidates. Novan has created a proprietary Nitricil technology platform enabling the development of new chemical entities, or NCEs, with sustained delivery of nitric oxide. To date, we have focused primarily on nitric oxide's role in dermatological diseases, but have recently announced an expansion of the platform into the areas of women's health and gastroenterology.  ... More ...  



Risk Grade

Where does NOVN fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 2.43
Open Date:
Aug. 23, 2019
Close Price:
$ 2.45
Close Date:
Aug. 23, 2019


Consensus Recommendation

Analyst Info